Pharmaceutical Formulation and Characterization of Dipeptide Nanotubes for Drug Delivery Applications
Authors:
Open Access
- 2 June 2020
- journal article
- research article
- Published by Wiley in Macromolecular Bioscience
- Vol. 20 (7) , 2000115
Abstract
Peptide nanotubes are promising materials for a variety of biomedical applications with ultrashort (≤7 amino acids) forms providing particular promise for clinical translation. The manufacture of peptide nanotubes has, however, been associated with toxic organic solvents restricting clinical use. The purpose of this work is to formulate dipeptide nanotubes using mild techniques easily translated to industrial upscale and to characterize their physiochemical and biological properties. Phenylalanine‐phenylalanine variants can be successfully formulated using distilled water as demonstrated here. Formulations are homogenous in shape (tubular), with apparent size (50–260 nm) and a zeta potential of up to +30 mV. L‐(H2N‐FF‐COOH), and D‐enantiomers (H2N‐ff‐COOH) demonstrate no toxicity against glioblastoma cells and are explored for ability to deliver a model hydrophilic molecule, sodium fluorescein, at pH 5.5 (tumor) and 7.4 (physiological). Peptide nanotubes loaded with >85% sodium fluorescein, demonstrate burst release characteristics, fitting the Weibull model of drug release. This research provides important data contributing to the pharmaceutical formulation of peptide nanotubes as drug delivery platforms for hydrophilic drugs.Keywords
Funding Information
- Royal Society (IE160988, RG150171)
- Engineering and Physical Sciences Research Council (EP/S031561/1)
This publication has 84 references indexed in Scilit:
- Nanoparticle mediated non-covalent drug deliveryAdvanced Drug Delivery Reviews, 2013
- Structural and Photophysical Properties of Peptide Micro/Nanotubes Functionalized with HypericinThe Journal of Physical Chemistry B, 2013
- Molecular Insights on the Cyclic Peptide Nanotube-Mediated Transportation of Antitumor Drug 5-FluorouracilMolecular Pharmaceutics, 2010
- Self-assembly and application of diphenylalanine-based nanostructuresChemical Society Reviews, 2010
- Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein AggregatesPharmaceutical Research, 2010
- Nanoparticle-based targeted drug deliveryExperimental and Molecular Pathology, 2009
- Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotesCell Death & Differentiation, 2009
- Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and CaveatsNanomedicine, 2008
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Using circular dichroism spectra to estimate protein secondary structureNature Protocols, 2006